Clearbridge Investments LLC boosted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 34.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,258,060 shares of the medical instruments supplier’s stock after buying an additional 1,353,040 shares during the period. Clearbridge Investments LLC owned about 2.29% of DENTSPLY SIRONA worth $328,313,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Howard Hughes Medical Institute raised its position in DENTSPLY SIRONA by 134.9% in the first quarter. Howard Hughes Medical Institute now owns 2,751 shares of the medical instruments supplier’s stock worth $172,000 after buying an additional 1,580 shares during the last quarter. Penserra Capital Management LLC raised its position in DENTSPLY SIRONA by 9.5% in the first quarter. Penserra Capital Management LLC now owns 2,760 shares of the medical instruments supplier’s stock worth $172,000 after buying an additional 240 shares during the last quarter. Howland Capital Management LLC purchased a new position in DENTSPLY SIRONA during the first quarter worth about $203,000. TNB Financial purchased a new position in DENTSPLY SIRONA during the first quarter worth about $259,000. Finally, Atria Investments LLC raised its position in DENTSPLY SIRONA by 6.3% in the first quarter. Atria Investments LLC now owns 4,473 shares of the medical instruments supplier’s stock worth $279,000 after buying an additional 265 shares during the last quarter. 94.92% of the stock is currently owned by hedge funds and other institutional investors.
Shares of DENTSPLY SIRONA Inc. (NASDAQ XRAY) traded down 0.41% during midday trading on Friday, hitting $62.65. The stock had a trading volume of 1,033,082 shares. DENTSPLY SIRONA Inc. has a one year low of $55.00 and a one year high of $65.68. The company has a market capitalization of $14.36 billion, a PE ratio of 40.32 and a beta of 1.27. The firm’s 50-day moving average is $63.96 and its 200 day moving average is $62.13.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Tuesday, May 9th. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by $0.01. The business had revenue of $900.50 million during the quarter, compared to the consensus estimate of $916.55 million. DENTSPLY SIRONA had a net margin of 9.42% and a return on equity of 7.37%. The business’s revenue was up 16.6% on a year-over-year basis. During the same period in the prior year, the company earned $0.69 earnings per share. Equities analysts expect that DENTSPLY SIRONA Inc. will post $2.84 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be issued a $0.0875 dividend. This represents a $0.35 annualized dividend and a dividend yield of 0.56%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio is presently 22.58%.
COPYRIGHT VIOLATION WARNING: This article was originally reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this article on another site, it was illegally stolen and reposted in violation of US and international copyright law. The original version of this article can be read at https://www.chaffeybreeze.com/2017/07/29/dentsply-sirona-inc-nasdaqxray-shares-bought-by-clearbridge-investments-llc-updated-updated-updated.html.
A number of research firms recently issued reports on XRAY. BidaskClub lowered DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Friday. Credit Suisse Group reissued an “outperform” rating and issued a $75.00 price target (up previously from $67.00) on shares of DENTSPLY SIRONA in a research note on Thursday, July 13th. HC Wainwright started coverage on DENTSPLY SIRONA in a research note on Tuesday, July 11th. They issued a “buy” rating and a $74.00 price target on the stock. Zacks Investment Research raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price target on the stock in a research note on Thursday, July 13th. Finally, Cleveland Research raised DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research note on Tuesday, May 23rd. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and nine have issued a buy rating to the company. DENTSPLY SIRONA currently has a consensus rating of “Buy” and an average target price of $67.92.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.